News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/16/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/12/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on CareMax, Inc.|
Txns:
| Granted 33,750 options to buy
@ $0 |
|
| 05/11/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 03/13/2023 |
SC 13D/A
| DEERFIELD MANAGEMENT COMPANY, L.P. reports a 16.4% stake in CareMax, Inc. |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/07/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Bought 650,000 shares
@ $33.5, valued at
$21.8M
|
|
| 11/07/2022 |
SC 13D/A
| DEERFIELD MANAGEMENT COMPANY, L.P. reports a 20.7% stake in CareMax, Inc. |
| 09/20/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 2,777,777 shares
@ $3.15, valued at
$8.7M
|
|
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/15/2022 |
SC 13D/A
| DEERFIELD MANAGEMENT COMPANY, L.P. reports a 20.8% stake in CareMax, Inc. |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/28/2022 |
SC 13D/A
| DEERFIELD MANAGEMENT COMPANY, L.P. reports a 22.5% stake in CareMax, Inc. |
| 11/16/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Converted 40 shares
@ $0
Converted 85,113 shares
@ $0
Bought 50,000 options to buy
@ $1000, valued at
$50M
Disposed of 707,960 options to buy
@ $0
Disposed of 14,887 options to buy
@ $0
Converted 40 options to buy
@ $0
Converted 85,113 options to buy
@ $0
Acquired 3,177,543 options to buy
@ $11.5, valued at
$36.5M
Acquired 625,000 options to buy
@ $11.5, valued at
$7.2M
|
|
| 10/28/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Converted 756,472 shares
@ $0
Bought 387,500 shares
@ $16, valued at
$6.2M
Converted 7,186,489 preferred shares
@ $0 |
|
| 10/21/2021 |
3
| Flynn James E (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
|
|
|